|  Help  |  About  |  Contact Us

Publication : Lyn inhibits osteoclast differentiation by interfering with PLCgamma1-mediated Ca2+ signaling.

First Author  Yoon SH Year  2009
Journal  FEBS Lett Volume  583
Issue  7 Pages  1164-70
PubMed ID  19285079 Mgi Jnum  J:147997
Mgi Id  MGI:3843133 Doi  10.1016/j.febslet.2009.03.005
Citation  Yoon SH, et al. (2009) Lyn inhibits osteoclast differentiation by interfering with PLCgamma1-mediated Ca2+ signaling. FEBS Lett 583(7):1164-70
abstractText  Osteoclasts differentiate from macrophage-lineage cells to become specialized for bone resorption function. By a proteomics approach, we found that Lyn was down-regulated by the osteoclast differentiation factor, receptor activator of NF-kappaB ligand (RANKL). The forced reduction of Lyn caused a striking increase in the RANKL-induced PLCgamma1, Ca(2+), and NFATc1 responses during differentiation. These data suggest that Lyn plays a negative role in osteoclastogenesis by interfering with the PLCgamma1-mediated Ca(2+) signaling that leads to NFATc1 activation. Consistent with the in vitro results, in vivo injection of Lyn specific siRNA into mice calvariae provoked a fulminant bone resorption. Our study provides the first evidence of the involvement of Lyn in the negative regulation of osteoclastogenesis by RANKL.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression